{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:23:37Z","timestamp":1786548217347,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1111\/j.1572-0241.2008.02050.x","type":"journal-article","created":{"date-parts":[[2008,8,5]],"date-time":"2008-08-05T13:28:31Z","timestamp":1217942911000},"page":"2799-2806","source":"Crossref","is-referenced-by-count":95,"title":["Comparison of Interferon-Gamma Release Assay\n                    <i>Versus<\/i>\n                    Tuberculin Skin Test for Tuberculosis Screening in Inflammatory Bowel Disease"],"prefix":"10.14309","volume":"103","author":[{"given":"Alain M.","family":"Schoepfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Flogerzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Fallegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Nicod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Seibold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 4","key":"10.1111\/j.1572-0241.2008.02050.x-BIB1","doi-asserted-by":"crossref","first-page":"iv2","DOI":"10.1136\/ard.2005.044941","article-title":"Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005","volume":"64","author":"Furst","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)60078-6","article-title":"Disseminated tuberculosis after anti-TNFalpha treatment","volume":"369","author":"Malipeddi","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.berh.2006.06.002","article-title":"Problems encountered during anti-tumour necrosis factor therapy","volume":"20","author":"Desai","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1445-5994.2004.00710.x","article-title":"Tumour necrosis factor inhibitors: Risks and benefits in patients with rheumatoid arthritis","volume":"34","author":"Roberts","year":"2004","journal-title":"Intern Med J"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/ard.2005.043166","article-title":"Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis","volume":"65","author":"Schiff","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.20009","article-title":"Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB8","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1572-0241.2001.03836.x","article-title":"Reactivation tuberculosis in a patient with anti-TNF-alpha treatment","volume":"96","author":"N\u00fa\u00f1ez Martinez","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/0885066604267854","article-title":"Serious infections associated with anticytokine therapies in the rheumatic diseases","volume":"19","author":"Giles","year":"2004","journal-title":"J Intensive Care Med"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB10","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1177\/106002809603001115","article-title":"Corticosteroids in tuberculosis","volume":"30","author":"Cisneros","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB11","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/art.21734","article-title":"The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: A large, randomized, placebo-controlled trial","volume":"54","author":"Westhovens","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1183\/09031936.06.00110205","article-title":"Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients","volume":"28","author":"Piana","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","article-title":"The tuberculin skin test","volume":"17","author":"Huebner","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/thorax.57.9.804","article-title":"A meta-analysis of the effect of Bacille Calmette Gu\u00e9rin vaccination on tuberculin skin test measurements","volume":"57","author":"Wang","year":"2002","journal-title":"Thorax"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1086\/426434","article-title":"Influence of bacille Calmette-Gu\u00e9rin vaccination on size of tuberculin skin test reaction: to what size?","volume":"40","author":"Tissot","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0954-6111(97)90031-7","article-title":"Diagnostic strategy for pulmonary tuberculosis in a low-incidence country: Results of chest X-ray and sputum cultured for Mycobacterium tuberculosis","volume":"91","author":"Wilcke","year":"1997","journal-title":"Respir Med"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB17","first-page":"443","article-title":"Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection","volume":"2","author":"Streeton","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB18","first-page":"555","article-title":"Effect of anti-tuberculosis treatment on the tuberculin interferon-gamma response in tuberculin skin test (TST) positive health care workers and patients with tuberculosis","volume":"4","author":"Stuart","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200402-179OC","article-title":"Specific detection of tuberculosis infection: An interferon-gamma-based assay using new antigens","volume":"170","author":"Mori","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB20","first-page":"49","article-title":"Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States","volume":"54","author":"Mazurek","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB21","unstructured":"21.\u2002NHS. National Institute for Health and Clinical Excellence. Tuberculosis: Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Available at: http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG033niceguideline.pdf. Accessed February 13, 2008."},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1183\/09031936.06.00016906","article-title":"Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection","volume":"28","author":"Lee","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/rccm.200509-1516PP","article-title":"An update on the diagnosis of tuberculosis infection","volume":"174","author":"Richeldi","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB24","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","year":"2000","unstructured":"24.\u2002Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-47.","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB25","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1503\/cmaj.1031981","article-title":"Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic)","volume":"171","author":"McGinn","year":"2004","journal-title":"CMAJ"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB26","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/thorax.57.12.1010","article-title":"Induced sputum and bronchoscopy in the diagnosis of pulmonary tuberculosis","volume":"57","author":"McWilliams","year":"2002","journal-title":"Thorax"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1164\/ajrccm\/145.1.36","article-title":"A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong","volume":"145","author":"Hong Kong Chest Service\/Tuberculosis Research Centre MBMRC","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1086\/514016","article-title":"Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: Effect of human immunodeficiency virus infection","volume":"176","author":"Converse","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1128\/CDLI.8.2.339-345.2001","article-title":"Cell-mediated immune response to tuberculosis antigens: Comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture","volume":"8","author":"Katial","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB30","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1086\/340397","article-title":"Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations","volume":"34","author":"Bellete","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","article-title":"Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: Performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay","volume":"67","author":"Matulis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB32","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/jama.286.14.1740","article-title":"Comparison of a whole-blood interferon-gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection","volume":"286","author":"Mazurek","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0196-6553(02)48240-5","article-title":"Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection","volume":"31","author":"Fietta","year":"2003","journal-title":"Am J Infect Control"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2215\/CJN.01280406","article-title":"Detecting latent tuberculosis infection in hemodialysis patients: A head-to-head comparion of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel","volume":"2","author":"Passalent","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1086\/504358","article-title":"Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers","volume":"27","author":"Harada","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB36","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/ard.2007.069799","article-title":"Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy","volume":"66","author":"Sellam","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-7-56","article-title":"Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test","volume":"7","author":"Brock","year":"2006","journal-title":"Respir Res"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB38","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00296-007-0361-2","article-title":"Interferon gamma assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration","volume":"27","author":"Takahashi","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1542-3565(04)00060-6","article-title":"High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy","volume":"2","author":"Mow","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1465-9921-7-77","article-title":"Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons","volume":"7","author":"Diel","year":"2006","journal-title":"Respir Res"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB41","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/CDLI.6.6.934-937.1999","article-title":"Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis","volume":"6","author":"Johnson","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB42","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","article-title":"Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review","volume":"4","author":"Pai","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/09031936.06.00005906","article-title":"Direct costs of three models for the screening of latent tuberculosis infection","volume":"28","author":"Wrighton-Smith","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1572-0241.2008.02050.x-BIB44","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1378\/chest.06-2728","article-title":"Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany","volume":"131","author":"Diel","year":"2007","journal-title":"Chest"}],"container-title":["The American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000434-200811000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:23:27Z","timestamp":1786544607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-200811000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1572-0241.2008.02050.x","relation":{},"ISSN":["0002-9270","1572-0241"],"issn-type":[{"value":"0002-9270","type":"print"},{"value":"1572-0241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}